Evidence map›Paper›PMID 34832640›Full record

ArticlePathogens (Basel, Switzerland)2021

Fusaricidins, Polymyxins and Volatiles Produced by

Pascal Mülner, Elisa Schwarz, Kristin Dietel, Stefanie Herfort, Jennifer Jähne, Peter Lasch, Tomislav Cernava, Gabriele Berg, Joachim Vater

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. From Biocontrol to Synthesis: Innovative Progress ofInternational journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Advancing sustainable practices withAIMS microbiology · 2025
    Review
  11. Article
  12. Nitrogen-FixingMicroorganisms · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Biocontrol potential of lipopeptides produced byFrontiers in microbiology · 2023
    Article
  18. Review
  19. EndophyticFrontiers in plant science · 2022
    Article
  20. Active Metabolites From the EndophyteFrontiers in chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Pascal MülnerABITEP GmbH, Glienicker Weg 185, 12489 Berlin, Germany.
Elisa SchwarzABITEP GmbH, Glienicker Weg 185, 12489 Berlin, Germany.
Kristin DietelABITEP GmbH, Glienicker Weg 185, 12489 Berlin, Germany.
Stefanie HerfortRobert Koch-Institut, ZBS6, Proteomics and Spectroscopy, Seestr 10, 13353 Berlin, Germany.
Jennifer JähneRobert Koch-Institut, ZBS6, Proteomics and Spectroscopy, Seestr 10, 13353 Berlin, Germany.
Peter LaschRobert Koch-Institut, ZBS6, Proteomics and Spectroscopy, Seestr 10, 13353 Berlin, Germany.
Tomislav CernavaInstitute of Environmental Biotechnology, Graz University of Technology, Petergasse 12, 8010 Graz, Austria.ORCID 0000-0001-7772-4080
Gabriele BergInstitute of Environmental Biotechnology, Graz University of Technology, Petergasse 12, 8010 Graz, Austria.
Joachim VaterRobert Koch-Institut, ZBS6, Proteomics and Spectroscopy, Seestr 10, 13353 Berlin, Germany.ORCID 0000-0002-4478-4244
Robert Koch Institute · DEGraz University of Technology · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioactive peptidesGC–MSMALDI-TOF mass spectrometryP. polymyxavolatiles

Identifiers

PMID34832640
PMCPMC8621861
OpenAlexW3211697429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.